Anna-Barbara Moscicki, PhD

Anna-Barbara Moscicki, MD

Professor, Department of Pediatrics
Chief, Adolescent and Young Adult Medicine

Specialty

Adolescent Medicine, Pediatrics

Institutional Affiliation

Ronald Reagan UCLA Medical Center
UCLA Medical Center, Santa Monica
UCLA Mattel Children's Hospital

Languages

English, Polish

Education

Fellowships

Medical Microbiology, Stanford University, Howard Hughes Medical Institute, 1987 - 1989
Sexually Transmitted Disease and Laboratory Medicine, UCSF School of Medicine, 1984 - 1985
Adolescent Medicine, UCSF School of Medicine, 1982 -1984

Internship

Pediatrics, Children's Hospital at Vanderbilt, 1979 - 1980

Degree

MD, Northwestern University, 1979

Residency

Pediatrics, Children's Hospital at Vanderbilt, 1981 - 1982

Board Certifications

Adolescent Medicine, American Board of Family Practice, 1994, 2000, 2008
Pediatrics, American Board of Pediatrics, 1984

Contact Information

Scientific Interests

Dr. Anna-Barbara Moscicki's research interests include sexually transmitted diseases, specifically, human papillomavirus (HPV) and HIV infections in adolescents; tobacco addiction in adolescents; educational motivation for adherence to cervical cancer screening guidelines; text messaging and HPV vaccine uptake; HPV therapeutic vaccine and point of care testing for cervical cancer screening.

Highlighted Publications

Speicher DJ, Ramirez-Amador V, Dittmer DP, Webster-Cyriaque J, Goodman MT, Moscicki AB. Viral infections associated with oral cancers and diseases in the context of HIV: a workshop report. Oral Dis. 2016 Apr;22 Suppl 1:181-92. doi: 10.1111/odi.12418.

Moscicki AB, Darragh TM, Berry-Lawhorn JM, Roberts JM, Khan MJ, Boardman LA, Chiao E, Einstein MH, Goldstone SE, Jay N, Likes WM, Stier EA, Welton ML, Wiley DJ, Palefsky JM. Screening for Anal Cancer in Women. J Low Genit Tract Dis. 2015 Jul;19(3 Suppl 1):S27-42. doi: 10.1097/LGT.0000000000000117.

Scott ME, Ma Y, Farhat S, Moscicki AB. Expression of nucleic acid-sensing Toll-like receptors predicts HPV16 clearance associated with an E6-directed cell-mediated response. Int J Cancer. 2015 May 15;136(10):2402-8. doi: 10.1002/ijc.29283. Epub 2014 Oct 30.

Scott ME, Shvetsov YB, Thompson PJ, Hernandez BY, Zhu X, Wilkens LR, Killeen J, Vo DD, Moscicki AB, Goodman MT. Cervical cytokines and clearance of incident human papillomavirus infection: Hawaii HPV cohort study. Int J Cancer. 2013 Sep 1;133(5):1187-96. doi: 10.1002/ijc.28119. Epub 2013 Mar 16.

Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, Garcia FA, Moriarty AT, Waxman AG, Wilbur DC, Wentzensen N, Downs LS Jr, Spitzer M, Moscicki AB, Franco EL, Stoler MH, Schiffman M, Castle PE, Myers ER; ACS-ASCCP-ASCP Cervical Cancer Guideline Committee. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin. 2012 May-Jun;62(3):147-72. doi: 10.3322/caac.21139. Epub 2012 Mar 14.